Jeff Geschwind, MD – Innovator in Cancer Drugs Founder of Cage Pharma, Jeff Geschwind, MD, researches tumor metabolism-targeting drugs, particularly glycolysis inhibitors. His entrepreneurial vision accelerates novel cancer treatments, bridging gaps between lab research and clinical applications. https://www.linkedin.com/in/jeff-geschwind-037200174